SLC2A1 and hepatocellular carcinoma: In addition, the m6A enrichment and SLC2A1-DT levels were decreased or increased in HCC cells subjected to METTL3 inhibition or upregulation (Fig. 6I-J, Fig. S5D-F), respectively.